His clinical interests are in GI and GU cancers, and melanoma. He is an active clinical researcher and leads a development programme of Oraxol, an oral taxane. With the Cancer Society, he is a prominent advocate for improved cancer control and cancer services, with regular appearances on TV, radio, and print, as well as in a multitude of ministry committees. He co-led the Cancer Care at a Crossroads conference which resulted in a re-boot of the recently released cancer strategy, and was on the steering group for its development.
He wants to see New Zealanders receiving world class cancer care no matter who they are or where they live, and thinks that to achieve this we need clinical, research and policy strategies that are unapologetically ambitious, with patient outcomes at the heart of every endeavour.